Compare VLN & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VLN | INO |
|---|---|---|
| Founded | 2006 | 1979 |
| Country | Israel | United States |
| Employees | 233 | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.9M | 114.0M |
| IPO Year | N/A | 1999 |
| Metric | VLN | INO |
|---|---|---|
| Price | $2.12 | $1.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | $3.00 | ★ $6.75 |
| AVG Volume (30 Days) | ★ 3.9M | 2.2M |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 54.18 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $42,220,086.00 |
| Revenue This Year | $8.37 | $20,156.19 |
| Revenue Next Year | $16.99 | $421.95 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.37 |
| 52 Week Low | $1.10 | $1.03 |
| 52 Week High | $3.71 | $2.86 |
| Indicator | VLN | INO |
|---|---|---|
| Relative Strength Index (RSI) | 39.13 | 38.36 |
| Support Level | $1.48 | $1.03 |
| Resistance Level | $2.64 | $1.23 |
| Average True Range (ATR) | 0.40 | 0.08 |
| MACD | -0.19 | -0.02 |
| Stochastic Oscillator | 21.43 | 6.41 |
Valens Semiconductor Ltd is a provider of semiconductor products, pushing the boundaries of connectivity by enabling long-reach, high-speed video, and data transmission for the audio-video and automotive industries. It operates in two segments: Cross Industry Business, which includes solutions for the non-automotive verticals, including audio-video, industrial, machine vision and medical markets, that deliver superior, plug-and-play convergence and distribution of different interfaces, through a single long-distance category cable; and Automotive segment products enable safe and resilient high-speed in-vehicle connectivity for car architectures, realizing the vision of connected and autonomous cars. The company's geographical revenue is derived from Hungary.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.